' Impressive ' Outcomes Sans Chemo in Poor-Prognosis ALL ' Impressive ' Outcomes Sans Chemo in Poor-Prognosis ALL

Chemo-free targeted therapy yielded high rates of molecular response,"impressive" survival at 18 months with few toxic effects in a phase 2 trial of adults with Ph+ acute lymphoblastic leukemia (ALL).Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news